4-methoxyamphetamine has been researched along with End Stage Liver Disease in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 13 (44.83) | 24.3611 |
| 2020's | 16 (55.17) | 2.80 |
| Authors | Studies |
|---|---|
| Aqel, B; Croome, KP; Heimbach, JK; Mathur, AK; Paz-Fumagalli, R; Rosen, CB; Taner, CB; Taner, T; Yang, L | 1 |
| Aqel, B; Brooks, A; Das, D; Heilman, R; Hewitt, W; Jadlowiec, CC; Lizaola-Mayo, B; Macdonough, E; Mathur, AK; Moss, A; Pont, K; Reddy, KS; Valenti, K | 1 |
| Ammann, AM; Cortez, AR; Delman, AM; Quillin, RC; Schepers, E; Shah, SA; Turner, KM; Van Haren, RM; Vaysburg, DM; Wilson, GC | 1 |
| Bekki, Y; Fenig, Y; Florman, S; Myers, B | 1 |
| Cama, E; Drysdale, K; Mao, L; Rance, J; Treloar, C | 1 |
| Dhand, A; Misawa, R; Nishida, S; Okumura, K; Sogawa, H; Veillette, G | 1 |
| Kumar, S; Pedersen, R; Sahajpal, A | 2 |
| Abt, PL; Bittermann, T; Kathawate, RG | 1 |
| Aqel, B; Brooks, A; Buckner Petty, SA; Das, D; Egbert, LK; Jadlowiec, CC; Mahdi, G; Mathur, AK; Moss, A; Ohara, SY; Reddy, KS | 1 |
| Dodge, JL; Grab, JD; Mehta, N; Roll, G; Silverstein, J; Yao, FY | 1 |
| Aqel, BA; Heilman, R; Heimbach, J; Hewitt, W; Jadlowiec, CC; Mathur, AK; Morgan, P; Moss, AA; Nunez-Nateras, R; Reddy, KS; Rosen, C; Taner, T | 1 |
| Eckhoff, DE; Fleishman, A; Haque, OJ; Khwaja, K; Roth, EM | 1 |
| Alebrahim, M; Black, S; El-Hinnawi, A; Helfrich, K; Limkemann, A; Logan, A; Mumtaz, K; Schenk, A; Singh, N; Washburn, K | 1 |
| Calvo, J; Cambra, F; Caso, O; Cortés, M; García, A; García-Conde, M; García-Sesma, A; Jiménez-Romero, C; Justo, I; Loinaz, C; Manrique, A; Marcacuzco, A | 1 |
| Bustamante, FJ; Fernandez, JR; Gastaca, M; Palomares, I; Prieto, M; Ruiz, P; Salvador, P; Senosiain, M; Testillano, M; Valdivieso, A; Ventoso, A | 1 |
| Croome, KP; Keaveny, AP; Lee, DD; Nguyen, JH; Taner, CB | 1 |
| Dutkowski, P; Isaac, J; Kalisvaart, M; Laing, RW; Mergental, H; Mirza, DF; Muiesan, P; Perera, T; Scalera, I; Schlegel, A | 1 |
| Wanis, K | 1 |
| Christine, H; Crawford, M; deRoo, RA; van der Stelt, JM; Verran, DJ | 1 |
| Abe, S; Iwaya, S; Kobayashi, A; Kunii, H; Miyata, M; Nakamura, Y; Nakazato, K; Oikawa, M; Owada, T; Saitoh, S; Sato, T; Shimizu, T; Sugimoto, K; Suzuki, H; Suzuki, S; Takeishi, Y; Takiguchi, M; Yamaki, T; Yamauchi, H; Yoshihisa, A | 1 |
| Burns, JM; Lee, DD; Nguyen, JH; Perry, DK; Singh, A; Taner, CB | 1 |
| Abbott, DE; Hoehn, RS; Paquette, IM; Paterno, F; Quillin, RC; Shah, SA; Singhal, A; Wima, K; Woodle, ES | 1 |
| Byrnes, K; Chapman, WC; Collins, K; Doyle, MB; Garonzik-Wang, J; Lin, Y; Lowell, JA; Nalbantoglu, I; Shenoy, S; Vachharajani, N; Wellen, J | 1 |
| Detry, O | 1 |
| Chapman, WC; Majella Doyle, MB | 1 |
| Clavien, PA; DeOliveira, ML; Dutkowski, P; Kron, P; Muiesan, P; Polak, WG; Scalera, I; Schlegel, A; Verhoeven, CJ | 1 |
3 review(s) available for 4-methoxyamphetamine and End Stage Liver Disease
| Article | Year |
|---|---|
What is known about the care and support provided for an ageing population with lived experience of chronic viral hepatitis as they near end-of-life: A scoping review.
Topics: Aging; Death; End Stage Liver Disease; Hepatitis C; Humans; Quality of Life | 2022 |
Impact of Donation After Circulatory Death Allografts on Outcomes After Liver Transplant for Hepatitis C: A Single-Center Experience and Review of the Literature.
Topics: Allografts; Brain Death; Death; End Stage Liver Disease; Graft Survival; Hepacivirus; Hepatitis C; Humans; Liver Neoplasms; Liver Transplantation; Retrospective Studies; Severity of Illness Index; Tissue Donors; Treatment Outcome | 2022 |
Impact of Donation After Circulatory Death Allografts on Outcomes Following Simultaneous Liver-Kidney Transplant: A Single-Center Experience and Review of the Literature.
Topics: Allografts; Brain Death; Death; End Stage Liver Disease; Graft Survival; Humans; Kidney; Kidney Transplantation; Liver Neoplasms; Liver Transplantation; Male; Retrospective Studies; Severity of Illness Index; Tissue and Organ Procurement; Tissue Donors | 2023 |
26 other study(ies) available for 4-methoxyamphetamine and End Stage Liver Disease
| Article | Year |
|---|---|
Classification of Distinct Patterns of Ischemic Cholangiopathy Following DCD Liver Transplantation: Distinct Clinical Courses and Long-term Outcomes From a Multicenter Cohort.
Topics: Death; End Stage Liver Disease; Graft Survival; Humans; Ischemia; Liver Transplantation; Necrosis; Retrospective Studies; Tissue and Organ Procurement; Tissue Donors | 2022 |
Donation after circulatory death transplant outcomes using livers recovered by local surgeons.
Topics: Death; End Stage Liver Disease; Graft Survival; Humans; Ischemia; Liver Transplantation; Retrospective Studies; Severity of Illness Index; Surgeons; Tissue and Organ Procurement; Tissue Donors; United States | 2022 |
The volume-outcomes relationship in donation after circulatory death liver transplantation.
Topics: Death; End Stage Liver Disease; Graft Rejection; Graft Survival; Humans; Liver Transplantation; Retrospective Studies; Tissue and Organ Procurement; Tissue Donors | 2022 |
The Implication of Center Volumes in Donation After Circulatory Death for Liver Transplantation: Donor-Recipient Selection and Outcomes.
Topics: Death; Donor Selection; End Stage Liver Disease; Graft Survival; Humans; Liver Transplantation; Renal Dialysis; Retrospective Studies; Severity of Illness Index; Tissue and Organ Procurement; Tissue Donors | 2022 |
Outcomes of Liver Transplantation Using Machine Perfusion in Donation after Cardiac Death vs Brain Death in the US.
Topics: Adult; Brain Death; Death; End Stage Liver Disease; Graft Survival; Humans; Liver Transplantation; Middle Aged; Perfusion; Retrospective Studies; Severity of Illness Index; Tissue and Organ Procurement; Tissue Donors | 2023 |
Center expansion of liver transplants using donation after circulatory death organs is associated with reduced overall waitlist mortality.
Topics: Death; End Stage Liver Disease; Graft Survival; Humans; Liver Transplantation; Retrospective Studies; Severity of Illness Index; Tissue and Organ Procurement; Tissue Donors; Waiting Lists | 2023 |
Expanding Liver Transplant Opportunities in Older Patients With Nonconventional Grafts.
Topics: Aged; Death; End Stage Liver Disease; Graft Survival; Humans; Liver Transplantation; Retrospective Studies; Severity of Illness Index; Tissue and Organ Procurement; Tissue Donors | 2023 |
Donation After Circulatory Death Is Associated With Similar Posttransplant Survival in All but the Highest-Risk Hepatocellular Carcinoma Patients.
Topics: Carcinoma, Hepatocellular; Death; End Stage Liver Disease; Graft Survival; Humans; Liver Neoplasms; Liver Transplantation; Neoplasm Recurrence, Local; Retrospective Studies; Severity of Illness Index; Tissue and Organ Procurement; Tissue Donors | 2020 |
Simultaneous liver-kidney transplantation from donation after cardiac death donors: an updated perspective.
Topics: Arizona; Brain Death; Death; End Stage Liver Disease; Graft Survival; Humans; Kidney; Kidney Transplantation; Minnesota; Retrospective Studies; Severity of Illness Index; Tissue and Organ Procurement; Tissue Donors; Treatment Outcome | 2020 |
Long-Term Outcomes of Early Experience in Donation After Circulatory Death Liver Transplantation: Outcomes at 10 Years.
Topics: Adult; Brain Death; Carcinoma, Hepatocellular; Death; End Stage Liver Disease; Female; Graft Survival; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Tissue and Organ Procurement; Tissue Donors | 2021 |
Donation After Circulatory Death Yields Survival Rates Similar to Donation After Brain Death Liver Transplant, Which Effectively Expands the Donor Pool.
Topics: Adolescent; Adult; Brain Death; Death; End Stage Liver Disease; Graft Survival; Humans; Liver Transplantation; Retrospective Studies; Severity of Illness Index; Survival Rate; Tissue and Organ Procurement; Tissue Donors; Treatment Outcome | 2021 |
Hemoderivative Transfusion in Liver Transplantation: Comparison Between Recipients of Grafts From Brain Death Donors and Recipients of Uncontrolled Donors After Circulatory Death.
Topics: Blood Transfusion; Brain Death; Death; End Stage Liver Disease; Graft Survival; Humans; Liver Transplantation; Retrospective Studies; Severity of Illness Index; Tissue Donors | 2021 |
Similar Results in Liver Transplantation From Controlled Donation After Circulatory Death Donors With Normothermic Regional Perfusion and Donation After Brain Death Donors: A Case-Matched Single-Center Study.
Topics: Brain Death; Death; End Stage Liver Disease; Graft Survival; Humans; Liver Transplantation; Organ Preservation; Perfusion; Retrospective Studies; Severity of Illness Index; Tissue Donors | 2021 |
Waitlist Outcomes for Patients Relisted Following Failed Donation After Cardiac Death Liver Transplant: Implications for Awarding Model for End-Stage Liver Disease Exception Scores.
Topics: Death; Decision Support Techniques; End Stage Liver Disease; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Liver Diseases; Liver Transplantation; Male; Middle Aged; Models, Statistical; Patient Selection; Prognosis; Reoperation; Risk Factors; Tissue and Organ Procurement; Tissue Donors; Transplant Recipients; Waiting Lists | 2017 |
The UK DCD Risk Score: A new proposal to define futility in donation-after-circulatory-death liver transplantation.
Topics: Adult; Cold Ischemia; Death; End Stage Liver Disease; Female; Graft Rejection; Graft Survival; Humans; Liver; Liver Transplantation; Male; Medical Futility; Propensity Score; Risk Assessment; Risk Factors; Tissue and Organ Procurement; Tissue Donors; Transplants; Warm Ischemia | 2018 |
Discussion.
Topics: Death; End Stage Liver Disease; Humans; Liver Transplantation | 2018 |
Can we reduce ischemic cholangiopathy rates in donation after cardiac death liver transplantation after 10 years of practice? Canadian single-centre experience
Topics: Adult; Aged; Bile Duct Diseases; Canada; Databases, Factual; Death; End Stage Liver Disease; Female; Graft Survival; Humans; Ischemia; Liver Transplantation; Male; Middle Aged; Patient Selection; Retrospective Studies; Survival Analysis; Time Factors; Tissue and Organ Harvesting; Tissue and Organ Procurement; Tissue Donors; Transplant Recipients; Treatment Outcome; Warm Ischemia | 2019 |
Initial outcomes of using allografts from donation after cardiac death donors for liver transplantation in New South Wales.
Topics: Adolescent; Adult; Child; Child, Preschool; Death; Donor Selection; End Stage Liver Disease; Follow-Up Studies; Graft Survival; Humans; Liver Transplantation; Middle Aged; New South Wales; Patient Selection; Postoperative Complications; Practice Guidelines as Topic; Treatment Outcome; Young Adult | 2013 |
Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure.
Topics: Aged; Death; End Stage Liver Disease; Female; Heart Failure; Humans; International Normalized Ratio; Kaplan-Meier Estimate; Liver Diseases; Male; Prognosis; Proportional Hazards Models; Ultrasonography | 2014 |
Early allograft dysfunction in liver transplantation with donation after cardiac death donors results in inferior survival.
Topics: Adolescent; Adult; Aged; Allografts; Cholangiography; Death; End Stage Liver Disease; Female; Graft Survival; Humans; International Normalized Ratio; Ischemia; Kaplan-Meier Estimate; Liver; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Tissue Donors; Treatment Outcome; Young Adult | 2014 |
Hospital Resource Use with Donation after Cardiac Death Allografts in Liver Transplantation: A Matched Controlled Analysis from 2007 to 2011.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allografts; Brain Death; Death; End Stage Liver Disease; Female; Graft Survival; Hospital Costs; Humans; Liver Transplantation; Male; Matched-Pair Analysis; Middle Aged; Patient Readmission; Retrospective Studies; Tissue and Organ Procurement; Tissue Donors; Treatment Outcome; United States; Young Adult | 2015 |
Outcomes Using Grafts from Donors after Cardiac Death.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Death; Child; Death; Donor Selection; End Stage Liver Disease; Female; Follow-Up Studies; Graft Survival; Humans; Liver Transplantation; Male; Matched-Pair Analysis; Middle Aged; Retrospective Studies; Survival Analysis; Tissue Donors; Treatment Outcome; Young Adult | 2015 |
Discussion.
Topics: Death; Donor Selection; End Stage Liver Disease; Female; Humans; Liver Transplantation; Male; Tissue Donors | 2015 |
Donor Age in Liver Transplantation: Donation after Circulatory Death.
Topics: Death; Donor Selection; End Stage Liver Disease; Female; Humans; Liver Transplantation; Male; Tissue Donors | 2015 |
Liver Transplantation and Donor Age: In Reply to Detry.
Topics: Death; Donor Selection; End Stage Liver Disease; Female; Humans; Liver Transplantation; Male; Tissue Donors | 2015 |
First Comparison of Hypothermic Oxygenated PErfusion Versus Static Cold Storage of Human Donation After Cardiac Death Liver Transplants: An International-matched Case Analysis.
Topics: Cryopreservation; Death; End Stage Liver Disease; Female; Follow-Up Studies; Graft Survival; Humans; Liver Transplantation; Male; Middle Aged; Organ Preservation; Perfusion; Retrospective Studies; Time Factors; Tissue and Organ Procurement; Tissue Donors | 2015 |